Hjem › Neoplasmer efter histologisk type › Florida
Neoplasmer efter histologisk type kliniske forsøg i Florida
6 studier for Neoplasmer efter histologisk type søger deltagere på steder i Florida.
Byer i Florida
Officiel studietekst (engelsk)
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- University of Florida, Gainesville
- Mount Sinai Medical Center of Florida, Inc., Miami
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT05874921A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
- Moffitt Cancer Center, Tampa
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. aug. 2026 · NCT07075185Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Clermont Oncology Center, Clermont
- Mid Florida Hematology and Oncology Center, Orange City
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 29. jul. 2026 · NCT04198766Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Moffitt Cancer Center, Tampa
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 7. jul. 2026 · NCT07216443Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
- Clermont Oncology Center, Clermont
- Oncology & Hematology Associates of West Broward, Coral Springs
- Helios Clinical Research, Fort Lauderdale
- og 5 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 4. jun. 2026 · NCT06463665A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Memorial Healthcare System, Hollywood
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 27. maj 2026 · NCT03093116Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.